Onconic Therapeutics Inc. (KOSDAQ:476060)
South Korea · Delayed Price · Currency is KRW 23,950
-1,150 (-4.58%)
At close: Mar 20, 2026
Onconic Therapeutics Market Cap
Onconic Therapeutics has a market cap or net worth of 1.08 trillion as of March 20, 2026. Its market cap has increased by 546.99% in one year.
Market Cap
1.08T
Enterprise Value
1.02T
Revenue
53.39B
Ranking
n/a
PE Ratio
68.11
Stock Price
23,950.00
Market Cap Chart
Since December 19, 2024, Onconic Therapeutics's market cap has increased from 186.91B to 1.08T, an increase of 475.18%. That is a compound annual growth rate of 305.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 1.08T | 23.60% |
| Dec 30, 2025 | 869.78B | 392.69% |
| Dec 30, 2024 | 176.54B | -5.55% |
| Dec 19, 2024 | 186.91B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Hugel | 2.83T |
| Orum Therapeutics | 2.65T |
| Chabiotech | 1.72T |
| Pharmicell | 955.86B |
| GI Innovation | 936.98B |
| MEDIPOST | 906.79B |
| Proteina | 894.85B |
| Medy-Tox | 741.99B |